Brain cell transplant trial offers new hope for Parkinson's patients
NCT ID NCT05635409
Summary
This is the first-ever study in people to test a new stem cell therapy for Parkinson's disease. The goal is to see if transplanting lab-grown cells that can produce dopamine—a brain chemical lost in Parkinson's—directly into the brain is safe. Eight participants with moderate Parkinson's will receive the transplant and be closely monitored for three years to check for side effects and any early signs that it might help their symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cambridge University Hospitals NHS Foundation Trust
Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom
-
Region Skåne - Skåne University Hospital
Lund, 214 28, Sweden
Conditions
Explore the condition pages connected to this study.